Weiss Multi Strategy Advisers LLC Biomarin Pharmaceutical Inc Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $482,472 - $623,568	6,330 Added 21.37%	35,955 $3.47 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $222,968 - $247,632	-2,621 Reduced 8.13%	29,625 $2.62 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $539,669 - $624,467	-6,226 Reduced 16.18%	32,246 $2.8 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $1.23 Million - $1.65 Million	14,064 Added 57.62%	38,472 $3.74 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $797,403 - $1.07 Million	-9,853 Reduced 28.76%	24,408 $2.53 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.73 Million - $2.04 Million	21,016 Added 158.67%	34,261 $2.9 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $49,893 - $60,621	-698 Reduced 5.01%	13,245 $1.1 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $405,271 - $505,716	-5,456 Reduced 28.13%	13,943 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $5,809 - $7,409	-81 Reduced 0.42%	19,399 $1.71 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $31,777 - $36,324	425 Added 2.23%	19,480 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $51,271 - $57,572	679 Added 3.7%	19,055 $1.59 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $56,122 - $68,108	-751 Reduced 3.93%	18,376 $1.39 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $68,253 - $84,788	-940 Reduced 4.68%	19,127 $1.68 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $718,987 - $1.31 Million	-10,004 Reduced 33.27%	20,067 $1.53 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $354,315 - $553,275	-4,454 Reduced 12.9%	30,071 $3.71 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $105,270 - $142,853	-1,475 Reduced 4.1%	34,525 $2.92 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $64,269 - $86,370	1,000 Added 2.86%	36,000 $3.04 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $200,875 - $234,750	2,500 Added 7.69%	35,000 $3 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $1.47 Million - $1.73 Million	-17,500 Reduced 35.0%	32,500 $2.89 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $1.64 Million - $2.17 Million	-20,431 Reduced 29.01%	50,000 $4.26 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $898,720 - $1.01 Million	-9,569 Reduced 11.96%	70,431 $6.83 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $760,100 - $990,300	-10,000 Reduced 11.11%	80,000 $7.54 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $776,700 - $926,300	10,000 Added 12.5%	90,000 $7.3 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $807,600 - $951,300	10,000 Added 14.29%	80,000 $7.13 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $5.64 Million - $6.65 Million	70,000	70,000 $6.52 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account